Methylprednisolone Completed Phase 2 / 3 Trials for Dyskeratosis Congenita / Aplastic Anemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT00004323Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia